Torres H, Mustafayev K, Juneau R, Hwang J, Wang L, Angelidakis G
J Natl Compr Canc Netw. 2024; 22(2 D.
PMID: 38729204
PMC: 11774473.
DOI: 10.6004/jnccn.2023.7332.
Yibirin M, Mustafayev K, Hosry J, Pundhir P, Klingen J, Yepez Guevara E
Am J Gastroenterol. 2023; 118(9):1609-1617.
PMID: 37307533
PMC: 11809494.
DOI: 10.14309/ajg.0000000000002361.
Tagliamento M, Remon J, Giaj Levra M, De Maria A, Bironzo P, Besse B
JTO Clin Res Rep. 2023; 4(1):100446.
PMID: 36687558
PMC: 9853354.
DOI: 10.1016/j.jtocrr.2022.100446.
Ibraheem M, Habeeb Ghali H, Kareem F, Alqazaz A
Clin Exp Hepatol. 2023; 8(4):315-320.
PMID: 36683872
PMC: 9850300.
DOI: 10.5114/ceh.2022.122278.
Spera A
World J Hepatol. 2022; 14(3):525-534.
PMID: 35582286
PMC: 9055195.
DOI: 10.4254/wjh.v14.i3.525.
Screening and prevention of hepatitis C virus reactivation during chemotherapy.
Li Y, Hu T, Chen W, Hsu P, Chen H
World J Gastroenterol. 2021; 27(31):5181-5188.
PMID: 34497443
PMC: 8384748.
DOI: 10.3748/wjg.v27.i31.5181.
Successful treatment by on-demand glecaprevir and pibrentasvir for hepatitis C flare during R-CHOP in patients with diffuse large B-cell lymphoma: a case report.
Umemura M, Suda G, Tsukamoto S, Ebata K, Takahash S, Sasaki T
BMC Infect Dis. 2021; 21(1):389.
PMID: 33906643
PMC: 8077834.
DOI: 10.1186/s12879-021-06091-x.
Latent infection screening and prevalence in cancer patients born outside of Australia: a universal versus risk-based approach?.
Reynolds G, Haeusler G, Slavin M, Teh B, Thursky K
Support Care Cancer. 2021; 29(11):6193-6200.
PMID: 33763725
DOI: 10.1007/s00520-021-06116-w.
Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection.
Pritchard H, Hwang J, Angelidakis G, Yibirin M, Wang L, Miller E
J Viral Hepat. 2021; 28(5):844-848.
PMID: 33523503
PMC: 8928572.
DOI: 10.1111/jvh.13478.
Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy.
Ziogas D, Kostantinou F, Cholongitas E, Anastasopoulou A, Diamantopoulos P, Haanen J
J Immunother Cancer. 2020; 8(2).
PMID: 33067316
PMC: 7570225.
DOI: 10.1136/jitc-2020-000943.
Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct-acting antivirals-A prospective study.
Pritchard H, Jandhyala D, Hosry J, Angelidakis G, Torres H
JGH Open. 2020; 4(3):541-544.
PMID: 32514467
PMC: 7273696.
DOI: 10.1002/jgh3.12294.
Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.
Torres H, Lok A, Suarez-Almazor M, Warneke C, Kaseb A, Miller E
Support Care Cancer. 2020; 29(1):97-105.
PMID: 32314052
PMC: 9706509.
DOI: 10.1007/s00520-020-05456-3.
